2nd Annual National ABCD IPN-UK meeting

Authors

  • Suma Sugunendran Consultant, Derby Teaching Hospitals, NHS Foundation Trust, Royal Derby Hospital, Derby, UK
  • Peter Jennings Senior Teaching Fellow, University of Warwick and Diabetes Specialist Nurse, Royal Derby Hospital, Derby, UK

DOI:

https://doi.org/10.15277/bjd.2017.128

References

The REPOSE Study Group. Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomised trial (REPOSE). BMJ 2017;356:j1285. http:dx.doi.org/10.1136/bmj.j1285.

Pfützner A, Sachsenheimer D, Grenningloh M, et al. Using insulin infusion sets in CSII for longer than the recommended usage time leads to a high risk for adverse events: results from a prospective randomized crossover study. J Diabetes Sci Technol 2015;9:1292-8. http:dx.doi.org/10.1177/1932296815604438

UK Hypoglycaemia Study Group. Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration. Diabetologia 2007;50:1140-7.

National Institute for Health and Care Excellence (NICE). Type 1 diabetes in adults: diagnosis and management (2015 updated 2016). NICE guideline NG17. https://www. nice.org.uk/guidance/ng17

Geddes J, Wright RJ, Zammitt N, Deary IJ, Frier BM. An evaluation of methods of assessing impaired awareness of hypoglycaemia in type 1 diabetes. Diabetes Care 2007;30:1868-70.

Sugar SurfingTM. www.sugarsurfing.com

Downloads

Published

2017-06-25

Issue

Section

Meeting Reports